Latest Breaking News On - Potentially life threatening - Page 1 : comparemela.com

Postpartum depression drug zuranolone, now FDA-approved, is the first oral medication developed to treat PPD. It is expected to launch in the fourth quarter of 2023.

United statesTiffanyr farchioneArch womens ment healthJournal of women healthJ womens health larchmtDivision of psychiatryDrug administrationSage pharmaceuticalsUs drug enforcement administrationPotentially life threateningDrug evaluationAmerican journalEnforcement administrationCrisis lifelineWomens mentWomens health